InfuSystem to Participate at Craig-Hallum 19th Annual Institutional Investor Conference on Wednesday, June 1, 2022
InfuSystem Holdings, Inc. (NYSE American: INFU) announced that its CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance will participate in the Craig-Hallum's 19th Annual Institutional Investor Conference on June 1, 2022. This event will be held virtually, and management will conduct one-on-one meetings throughout the day. Interested investors can reach out to Craig-Hallum or contact Lytham Partners at 602-889-9700 or via email at infu@lythampartners.com. InfuSystem is a national healthcare service provider, specializing in outpatient care for durable medical equipment.
- None.
- None.
Management is scheduled to host virtual one-on-one meetings held throughout the day. Investors interested in arranging one-on-one meetings should contact your Craig-Hallum conference representative. Conversely, you may also call or email
About
Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, our share repurchase program and capital allocation strategy, business plans, growth initiatives, objectives and prospects, future operating or financial performance, guidance and expected new business relationships and the terms thereof (including estimated potential revenue under new or existing contracts). The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, our ability to successfully execute on our growth initiatives, our ability to enter into definitive agreements for the new business relationships on expected terms or at all, our ability to generate estimated potential revenue amounts under new or existing contracts, the uncertain impact of the COVID-19 pandemic, our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law, contributions from acquired businesses or new business lines, products or services and other risk factors disclosed in the Company’s most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-
Additional information about
View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005176/en/
602-889-9700
Source:
FAQ
What is InfuSystem's participation in the Craig-Hallum Conference on June 1, 2022?
How can investors arrange meetings with InfuSystem during the conference?
What services does InfuSystem Holdings, Inc. provide?
Where is InfuSystem Holdings, Inc. headquartered?